Fig. 3. Cumulative incidence rates of long-term clinical outcome according to virological response in compensatory cirrhosis and chronic hepatitis patients.

(A) End-stage liver disease in compensatory cirrhosis patients. (B) Decompensated cirrhosis in compensatory cirrhosis patients. (C) HCC in compensatory cirrhosis patients. (D) Compensated cirrhosis in chronic hepatitis patients. LLV, low-level viremia; MVR, maintained virological response; HCC, hepatocellular carcinoma.